Enzyme-containing nanoparticles as reactive oxygen species (ROS) scavengers are promising drug candidates for the treatment of pulmonary inflammation.
Due to their unique features, nanomaterials have gained considerable attention in recent years for applications in biomedicine. In particular, stimuli-responsive nanoparticles have shown promising results as a novel treatment approach for cancer. These nanoparticles can – for instance – produce heat upon a triggering stimulus (i.e. light). Current challenges include accumulating effective amounts of these nanoparticles in the tumor and efficiently delivering a stimulus that will elevate the temperature and, eventually, destroy the tumor. This project aims at finding approaches for the targeting and subsequent treatment of cancer cells with nanoparticles.